发明名称 |
USE OF IGF-1 |
摘要 |
The invention relates to the use of IGF-1 for the manufacture of a medicament for treatment of Type 1 diabetes mellitus, the medicament comprising a subcutaneous dose not greater than needed to achieve an IGF-1 serum level characteristic for healthy individuals i.e. a physiological replacement of serum IGF-1. This treatment would be especially valuable for the treatment of children or adolescents with Type 1 diabetes mellitus and could lead to improvements in their pubertal growth. |
申请公布号 |
WO9323071(A1) |
申请公布日期 |
1993.11.25 |
申请号 |
WO1993SE00425 |
申请日期 |
1993.05.14 |
申请人 |
KABI PHARMACIA AB |
发明人 |
DUNGER, DAVID, B.;SAVAGE, MARTIN, O.;SOENKSEN, PETER, H. |
分类号 |
A61K38/28;A61K38/27;A61K38/30;A61P3/08;A61P3/10;(IPC1-7):A61K37/36;A61K37/26 |
主分类号 |
A61K38/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|